Indicado en el tratamiento de la presión intraocular elevada (PIO) en pacientes con glaucoma de ángulo abierto o glaucoma pseudoexfoliativo, cuando la monoterapia con un betabloqueante tópico no es suficiente.
We use our own and third-party cookies to ensure the functioning of our website. By clicking “Accept”, you agree that cookies are stored on your device to improve site navigation, analyze site usage, and collaborate with our marketing studies. You can also configure them. See Cookies Policy